augmedix is a telemedicine charting service for healthcare providers that eliminates the 17 hours each week providers spend on ehr documentation. using wearable technology to connect their clinic with the augmedix charting service, providers can focus on what they do best: taking care of patients.
Company profile
Ticker
AUGX
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Malo Holdings Corp
SEC CIK
Corporate docs
IRS number
833299164
AUGX stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
18 Apr 24
8-K
Entry into a Material Definitive Agreement
15 Apr 24
S-8
Registration of securities for employees
27 Mar 24
10-K
2023 FY
Annual report
26 Mar 24
8-K
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
18 Mar 24
8-K
Entry into a Material Definitive Agreement
9 Jan 24
8-K
Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
5 Jan 24
8-K
Entry into a Material Definitive Agreement
29 Nov 23
8-K
Augmedix Announces Closing of Public Offering of Common Stock, Including Additional Investments from HCA Healthcare
21 Nov 23
8-K
Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock
20 Nov 23
Transcripts
AUGX
Earnings call transcript
2023 Q4
18 Mar 24
AUGX
Earnings call transcript
2023 Q3
6 Nov 23
AUGX
Earnings call transcript
2023 Q2
7 Aug 23
AUGX
Earnings call transcript
2023 Q1
12 May 23
AUGX
Earnings call transcript
2022 Q4
27 Mar 23
AUGX
Earnings call transcript
2022 Q3
15 Nov 22
AUGX
Earnings call transcript
2022 Q2
12 Aug 22
AUGX
Earnings call transcript
2022 Q1
10 May 22
AUGX
Earnings call transcript
2021 Q4
21 Mar 22
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 22.29 mm | 22.29 mm | 22.29 mm | 22.29 mm | 22.29 mm | 22.29 mm |
Cash burn (monthly) | 991.33 k | 392.58 k | 1.47 mm | 1.68 mm | 764.33 k | 1.57 mm |
Cash used (since last report) | 6.62 mm | 2.62 mm | 9.81 mm | 11.20 mm | 5.11 mm | 10.50 mm |
Cash remaining | 15.66 mm | 19.66 mm | 12.48 mm | 11.08 mm | 17.18 mm | 11.79 mm |
Runway (months of cash) | 15.8 | 50.1 | 8.5 | 6.6 | 22.5 | 7.5 |
Institutional ownership, Q3 2023
72.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 65 |
Opened positions | 22 |
Closed positions | 8 |
Increased positions | 17 |
Reduced positions | 17 |
13F shares | Current |
---|---|
Total value | 135.53 bn |
Total shares | 35.19 mm |
Total puts | 22.40 k |
Total calls | 58.20 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Redmile | 15.63 mm | $80.50 bn |
DCM Vi | 4.44 mm | $7.99 mm |
Samjo Capital | 2.91 mm | $15.00 bn |
McKesson Ventures | 1.88 mm | $2.23 mm |
Perkins Capital Management | 1.39 mm | $7.16 mm |
Vanguard | 1.04 mm | $5.35 bn |
G2 Investment Partners Management | 920.53 k | $4.74 bn |
Point72 Asset Management | 650.00 k | $3.35 bn |
Balyasny Asset Management | 591.27 k | $3.05 bn |
AFG American Financial | 500.00 k | $2.58 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Ian Shakil | Common Stock | Sell | Dispose S | No | Yes | 3.8 | 500 | 1.90 k | 3,000 |
15 Apr 24 | Ian Shakil | Common Stock | Option exercise | Acquire M | No | Yes | 0.86 | 500 | 430.00 | 3,500 |
15 Apr 24 | Ian Shakil | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 0.86 | 500 | 430.00 | 455,949 |
12 Apr 24 | Ian Shakil | Common Stock | Sell | Dispose S | No | Yes | 3.8165 | 19,544 | 74.59 k | 3,000 |
12 Apr 24 | Ian Shakil | Common Stock | Option exercise | Acquire M | No | Yes | 0.86 | 19,544 | 16.81 k | 22,544 |
12 Apr 24 | Ian Shakil | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 0.86 | 19,544 | 16.81 k | 456,449 |
11 Apr 24 | Ian Shakil | Common Stock | Sell | Dispose S | No | Yes | 3.934 | 24,778 | 97.48 k | 3,000 |
11 Apr 24 | Ian Shakil | Common Stock | Option exercise | Acquire M | No | Yes | 0.86 | 24,778 | 21.31 k | 27,778 |
11 Apr 24 | Ian Shakil | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 0.86 | 24,778 | 21.31 k | 475,993 |
10 Apr 24 | Ian Shakil | Common Stock | Sell | Dispose S | No | Yes | 3.8744 | 36,467 | 141.29 k | 3,000 |
News
Analyst Ratings For Augmedix
9 Apr 24
Evercore ISI Group Upgrades Augmedix to Outperform, Raises Price Target to $5
9 Apr 24
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
4 Apr 24
B. Riley Securities Reinstates Buy on Augmedix, Announces $5.5 Price Target
3 Apr 24
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
19 Mar 24
Press releases
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
4 Apr 24
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
18 Mar 24
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
12 Mar 24
Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
8 Mar 24
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Augmedix, Inc. (NASDAQ: AUGX)
22 Feb 24